SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001415889-21-001922
Filing Date
2021-04-06
Accepted
2021-04-06 19:47:30
Documents
2
Period of Report
2021-04-05

Document Format Files

Seq Description Document Type Size
1 form3-04062021_040415.html 3  
1 form3-04062021_040415.xml 3 1684
2 ex24-04062021_040417.htm EX-24 7385
  Complete submission text file 0001415889-21-001922.txt   10445
Mailing Address 512 2ND STREET, 4TH FLOOR SAN FRANCISCO CA 94107
Business Address 512 2ND STREET, 4TH FLOOR SAN FRANCISCO CA 94107 (415) 651-3316
Olema Pharmaceuticals, Inc. (Issuer) CIK: 0001750284 (see all company filings)

IRS No.: 300409740 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address C/O TURNING POINT THERAPEUTICS, INC. 10628 SCIENCE CENTER DRIVE, STE. 200 SAN DIEGO CA 92121
Business Address
Larson Yi (Reporting) CIK: 0001785987 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39712 | Film No.: 21810334